Edition:
India

Profile: GNI Group Ltd (2160.T)

2160.T on Tokyo Stock Exchange

2,803JPY
19 Apr 2019
Change (% chg)

¥85 (+3.13%)
Prev Close
¥2,718
Open
¥2,710
Day's High
¥2,805
Day's Low
¥2,710
Volume
157,500
Avg. Vol
197,430
52-wk High
¥5,630
52-wk Low
¥2,665

GNI Group Ltd. is a Japan-based company engaged in new drug production activities utilizing biotechnologies. The Company is engaged in the development of therapeutic agents for diseases that have many sufferers in Asian countries such as Japan and China, as well as clinical trial and bio-verification test businesses. It is engaged in research and development of therapeutic agents, including F647 for radiation pneumonia (RP) and idiopathic pulmonary fibrosis (IPF), F351 for liver fibrosis (cirrhosis) and F573 for acute hepatic insufficiency and acute chronic liver failure (ACLF).

Company Address

GNI Group Ltd

3F, Nihonbashi-Honcho YS Bldg
2-2-2, Nihonbashi Hon-cho
CHUO-KU   TKY   103-0023
P: +813.62143600
F: +813.62143668

Company Web Links